These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18768525)

  • 1. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
    Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
    Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
    Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
    Zhai Y; Qiu W; Dong XJ; Zhang XM; Xie WM; Zhang HX; Yuan XY; Zhou GQ; He FC
    Gut; 2007 Mar; 56(3):445-7. PubMed ID: 17339256
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
    Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
    Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
    Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
    Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS
    Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
    Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
    Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
    Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
    Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
    Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
    Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
    Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
    Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contribution of
    Shen TC; Hsia TC; Chao CY; Chen WC; Chen CY; Chen WC; Lin YT; Hsiao CL; Chang WS; Tsai CW; Bau DT
    Anticancer Res; 2017 Jul; 37(7):3563-3567. PubMed ID: 28668847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.